Contagion Health

Contagion Health specializes in providing valuable digital assets related to healthcare, focusing on infectious diseases and public health initiatives through its domain, ContagionHealth. com. Contagion Health operates primarily through the sale of its domain name, ContagionHealth. com, which serves as a digital asset for entities in the healthcare sector.

The company is based in San Francisco, US, and has undergone strategic developments since its founding. It received Seed financing in June 2010 from Founders Fund Angel, Habit Labs, Inc. and Y Combinator, marking a pivotal moment in its growth trajectory. The founder's history is not detailed in the available information.

ContagionHealth. com is a domain currently available for sale, serving as a potential digital asset for healthcare businesses, particularly those focusing on infectious diseases and public health initiatives. The core offering revolves around the domain name, which can be utilized by various entities, including healthcare providers, research institutions, and digital health platforms, seeking to establish an authoritative online presence. Its geographical reach is not limited to a specific region, having the potential to attract a global clientele engaged in health solutions and education, especially in areas with high public health concerns.

The revenue model for ContagionHealth. com is centered on the sale of the domain, priced at USD 3,695, or through a structured payment plan allowing customers to pay USD 307. 92 monthly over a year. Transactions can occur directly between the company and potential buyers, including businesses, organizations, or individuals looking to enhance their online footprint in the health sector.

The company facilitates these transactions through a user-friendly interface, enabling buyers to purchase the domain outright or enter into a financing agreement, generating revenue through this one-time transaction model. Contagion Health's future growth strategy includes plans to expand its digital asset offerings, potentially exploring new product development in the healthcare domain space. The company is positioned to leverage its existing assets to penetrate new markets with a focus on global health initiatives. The Seed financing received in June 2010 will support these initiatives, providing capital for strategic marketing and outreach efforts aimed at attracting a wider clientele.

The company does not have specific timelines for product launches or market expansions detailed in the available information.